Liquid Biopsies in SOLAR-1 Trial Predict Benefit of Alpelisib in PIK3CA-Mutant Breast Cancer
“SAN ANTONIO – Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared...
“SAN ANTONIO – Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared...
“SAN ANTONIO – Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy had...
“SAN ANTONIO – Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates...
SAN ANTONIO – Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease...
SAN ANTONIO – Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment...
“SAN ANTONIO – Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days after...
“SAN ANTONIO – Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk and...
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Subgroup analysis suggested the treatment may benefit patients with nonbasal-like disease SAN ANTONIO Treating patients who had early-stage triple-negative...
PHILADELPHIA – A program that provided individually tailored lifestyle recommendations for patients undergoing screening for colorectal cancer helped encourage...